Table 7. Potential impacts of the COVID-19 pandemic upon rabies activities.

Benefits	Limitations
Greater appreciation for diseases of nature and viral zoonoses specifically, such as rabies	Lessons lost, due to pandemic fatigue
Enhanced laboratory-based surveillance for lyssaviruses	Pathogen discovery focused primarily upon coronaviruses alone
Additional scrutiny to better understand how bat populations deal with lyssavirus burden	Unnecessary backlash against bat populations in general
Broader consideration of dogs now as pets, rather than livestock for consumption, closure of wildlife markets, and halting use of bats as bushmeat	Unpopular consumptive activities driven ever more underground
Shelter-in-place, limiting human exposure to rabid animals	Mass unemployment drives even greater community shifts and increases individual movements for resources
More animals vaccinated in aftermath of best practices, including use of drive-up clinics	Veterinary services not viewed as an essential activity compared to public health
New vaccine approaches provide insights for novel human prophylaxis	Unfulfilled promises and adverse events sour demand for novel products
Anti-viral strategies reap extension against other RNA viruses, such as in the Mononegavirales	No major cross-reactivity to rhabdoviruses
Broader One Health adoptive strategies	Anti-public health sentiments due to presumption of civil liberties lost
Global elimination of human rabies mediated via dogs (GEHRD) achieved before 2030 owing to greater preventive focus	GEHRD setback for decades owing to economic global repercussions